Effect of Environmental Parameters on Glycosylation of Recombinant Immunoglobulin G Produced from Recombinant CHO Cells
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Of nine cases studies, one showed ≥ 10% increase in GIx,23”
From Impact of process parameters on IgG glycosylation in CHO systems: a comprehensive quantitative analysis (2026) · cites this paper as [23]
In the citing paper
“Temperature shifts, pH, dissolved oxygen (DO), carbon dioxide partial pressure (pCO2), osmolality or small-molecule additives (e.g. sodium butyrate (NaBu)) can alter glycosylation machinery and downstream glycan profiles. However, their effects are highly context-dependent, varying with cell line, product type, and culture conditions.23”
From Impact of process parameters on IgG glycosylation in CHO systems: a comprehensive quantitative analysis (2026) · cites this paper as [23]
Citations
Cites
Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754
Malhotra, R., Wormald, M. R., Rudd, P. M., Fischer, P. B., Dwek, R. A., & Sim, R. B. (1995) · Nature Medicine · doi:10.1038/nm0395-237 · Cited by 786
Krapp, S., Mimura, Y., Jefferis, R., Huber, R., & Sondermann, P. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01250-0 · Cited by 674
Optimal and consistent protein glycosylation in mammalian cell culture
Hossler, P., Khattak, S. F., & Li, Z. J. (2009) · Glycobiology · doi:10.1093/glycob/cwp079 · Cited by 669
Raju, T. S., Briggs, J. B., Borge, S. M., & Jones, A. J. S. (2000) · Glycobiology · doi:10.1093/glycob/10.5.477 · Cited by 452
Optimization of humanized IgGs in glycoengineered Pichia pastoris
Li, H., Sethuraman, N., Stadheim, T. A., Zha, D., Prinz, B., Ballew, N., Bobrowicz, P., Choi, B.-K., Cook, W. J., Cukan, M., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1178 · Cited by 428
Scallon, B. J., Tam, S. H., McCarthy, S. G., Cai, A. N., & Raju, T. S. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.09.005 · Cited by 396
Control of Recombinant Monoclonal Antibody Effector Functions by Fc N‐Glycan Remodeling in Vitro
Hodoniczky, J., Zheng, Y. Z., & James, D. C. (2005) · Biotechnology Progress · doi:10.1021/bp050228w · Cited by 393
Tarentino, A. L., & Plummer, T. H. (1994) · Methods in Enzymology · doi:10.1016/0076-6879(94)30006-2 · Cited by 291
Anumula, K. R., & Dhume, S. T. (1998) · Glycobiology · doi:10.1093/glycob/8.7.685 · Cited by 262
Anumula, K. R. (2006) · Analytical Biochemistry · doi:10.1016/j.ab.2005.09.037 · Cited by 254
Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity
Nimmerjahn, F., Anthony, R. M., & Ravetch, J. V. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702936104 · Cited by 253
Trummer, E., Fauland, K., Seidinger, S., Schriebl, K., Lattenmayer, C., Kunert, R., Vorauer‐Uhl, K., Weik, R., Borth, N., Katinger, H., et al. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.21013 · Cited by 216
Büchs, J., Maier, U., Milbradt, C., & Zoels, B. (2000) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(20000620)68:6<589::aid-bit1>3.0.co;2-j · Cited by 207
A comparative analysis of disease-associated changes in the galactosylation of serum IgG
Parekh, R., Isenberg, D., Rook, G., Roitt, I., Dwek, R., & Rademacher, T. (1989) · Journal of Autoimmunity · doi:10.1016/0896-8411(89)90148-0 · Cited by 206
Metabolic control of recombinant protein N‐glycan processing in NS0 and CHO cells
Baker, K. N., Rendall, M. H., Hills, A. E., Hoare, M., Freedman, R. B., & James, D. C. (2001) · Biotechnology and Bioengineering · doi:10.1002/bit.1051 · Cited by 184
Lifely, M. R., Hale, C., Boyce, S., Keen, M. J., & Phillips, J. (1995) · Glycobiology · doi:10.1093/glycob/5.8.813 · Cited by 178
N-Glycosylation Design and Control of Therapeutic Monoclonal Antibodies
Sha, S., Agarabi, C. D., Brorson, K., Lee, D., & Yoon, S. (2016) · Trends in biotechnology · doi:10.1016/j.tibtech.2016.02.013 · Cited by 176
Altamirano, C., Paredes, C. J., Illanes, A., Cairó, J. J., & Gòdia, F. (2004) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2004.02.004 · Cited by 171
Yoon, S. K., Choi, S. L., Song, J. Y., & Lee, G. M. (2005) · Biotechnology and Bioengineering · doi:10.1002/bit.20353 · Cited by 159
Gawlitzek, M., Ryll, T., Lofgren, J., & Sliwkowski, M. B. (2000) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(20000620)68:6<637::aid-bit6>3.0.co;2-c · Cited by 158
Bollati‐Fogolín, M., Wagner, R., Etcheverrigaray, M., & Kratje, R. B. (2004) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2003.10.035 · Cited by 147
Ahn, W. S., Jeon, J., Jeong, Y., Lee, S. J., & Yoon, S. K. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.22006 · Cited by 126
Raju, T. S., Briggs, J. B., Chamow, S. M., Winkler, M. E., & Jones, A. J. S. (2001) · Biochemistry · doi:10.1021/bi010475i · Cited by 122
Furukawa, K., & Ohsuye, K. (1998) · Cytotechnology · doi:10.1023/a:1007934216507 · Cited by 112
Matsumoto, A., Shikata, K., Takeuchi, F., Kojima, N., & Mizuochi, T. (2000) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022794 · Cited by 111
Glycobiology: 'the function of sugar in the IgG molecule'.
Dwek, R. A., Lellouch, A. C., & Wormald, M. R. (1995) · PubMed Central · Cited by 107
Gawlitzek, M., Valley, U., & Wagner, R. (1998) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(19980305)57:5<571::aid-bit9>3.0.co;2-d · Cited by 97
Gawlitzek, M., Valley, U., & Wagner, R. (1998) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(19980305)57:5<518::aid-bit3>3.0.co;2-j · Cited by 97
Sugar Determines Antibody Activity
Burton, D. R., & Dwek, R. A. (2006) · Science · doi:10.1126/science.1131712 · Cited by 92
Performance comparison of protein A affinity resins for the purification of monoclonal antibodies
Swinnen, K., Krul, A., Goidsenhoven, I. V., Tichelt, N. V., Roosen, A., & Houdt, K. V. (2006) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.04.050 · Cited by 74
Nam, J. H., Zhang, F., Ermonval, M., Linhardt, R. J., & Sharfstein, S. T. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.21853 · Cited by 69
Anumula, K. R., & Du, P. (1999) · Analytical Biochemistry · doi:10.1006/abio.1999.4323 · Cited by 60
The changes in monosaccharide composition of immunoglobulin G in the course of rheumatoid arthritis
Gińdzieńska‐Sieśkiewicz, E., Klimiuk, P. A., Kisiel, D. G., Gindzieński, A., & Sierakowski, S. (2006) · Clinical Rheumatology · doi:10.1007/s10067-006-0370-7 · Cited by 50
The glycosylation pattern of a humanized IgGl antibody (D1.3) expressed in CHO cells
Routier, F. H., Davies, M. J., Bergemann, K., & Hounsell, E. F. (1997) · Glycoconjugate Journal · doi:10.1023/a:1018589704981 · Cited by 44
Potential and problems of animal cells in suspension culture
Leist, C., Meyer, H., & Fiechter, A. (1990) · Journal of Biotechnology · doi:10.1016/0168-1656(90)90049-h · Cited by 44
Heterogeneity of IgG Glycosylation in Adult Periodontal Disease
Novak, J., Tomana, M., Shah, G. R., Brown, R., & Mestecky, J. (2005) · Journal of Dental Research · doi:10.1177/154405910508401005 · Cited by 29
Dhume, S. T., Saddic, G. N., & Anumula, K. R. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-084-7_22 · Cited by 10
Cited by
The Current Landscape of Antibody-based Therapies in Solid Malignancies
Shah, A., Rauth, S., Aithal, A., Kaur, S., Ganguly, K., Orzechowski, C., Varshney, G. C., Jain, M., & Batra, S. K. (2021) · Theranostics · doi:10.7150/thno.52614 · Cited by 49
“The pattern of mAb glycosylation is dependent on many factors, such as the host cell used for mAb production, culture conditions, glucose, dissolved oxygen, pH, and temperature [134].”
BackgroundmAb Production Modeling and Design Space Evaluation Including Glycosylation Process
Yang, O., & Ierapetritou, M. (2021) · Processes · doi:10.3390/pr9020324 · Cited by 26
Kang, S. H., & Lee, C. (2021) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-020-0181-8 · Cited by 22
Sialylated and sulfated N-Glycans in MDCK and engineered MDCK cells for influenza virus studies
Byrd-Leotis, L. A., Jia, N., Matsumoto, Y., Lu, D., Kawaoka, Y., Steinhauer, D. A., & Cummings, R. D. (2022) · Scientific Reports · doi:10.1038/s41598-022-16605-5 · Cited by 19
Nacer, A., Kivi, G., Pert, R., Juronen, E., Holenya, P., Aliprandini, E., Amino, R., Silvie, O., Quinkert, D., Duff, Y. L., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.901253 · Cited by 8
“Glycosylation can be influenced by many factors including the cells used for the production of antibodies and the additives used in cell culture media (Kim et al., 2018; Ehret et al., 2019).”
Background
Metadata
- Authors
- Kim, S.-M., Chang, K.-H., & Oh, D. J.
- Affiliations
- Sejong University (KR)
- Inha University (KR)
- Corresponding author
- Oh, Duk Jae
- Venue
- Biotechnology and Bioprocess Engineering
- Published
- 2018-08
- Volume
- 23
- Issue
- 4
- Pages
- 456-464
- ISSN
- 1226-8372 (ISSN-L)
- 1976-3816
- OpenAlex
- W2890002306
- Cited by
- 11
- References
- 36
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2022: 2 · 2021: 3 · 2020: 1 · 2019: 1
- FWCI
- 0.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Biotechnology and Bioprocess Engineering (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Keywords
- site-specific glycosylation, CHO cells, Fc fragment, sialylation, culture conditions, cell passage number, pH and temperature effects, mannose, fructose, galactose, glucose replacement, therapeutic antibodies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.